MXPA01008347A - Compuestos quimicos. - Google Patents
Compuestos quimicos.Info
- Publication number
- MXPA01008347A MXPA01008347A MXPA01008347A MXPA01008347A MXPA01008347A MX PA01008347 A MXPA01008347 A MX PA01008347A MX PA01008347 A MXPA01008347 A MX PA01008347A MX PA01008347 A MXPA01008347 A MX PA01008347A MX PA01008347 A MXPA01008347 A MX PA01008347A
- Authority
- MX
- Mexico
- Prior art keywords
- chemical compounds
- compounds
- useful
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invencion se relaciona con derivados de benzaldehido que son utiles como agentes anticancer. Algunos de los compuestos de esta invencion son novedosos per se.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO990814A NO309305B1 (no) | 1999-02-19 | 1999-02-19 | Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater |
PCT/NO2000/000060 WO2000048610A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01008347A true MXPA01008347A (es) | 2004-03-10 |
Family
ID=19902986
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA01008346A MXPA01008346A (es) | 1999-02-19 | 2000-02-18 | Compuestos quimicos. |
MXPA01008347A MXPA01008347A (es) | 1999-02-19 | 2000-02-18 | Compuestos quimicos. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA01008346A MXPA01008346A (es) | 1999-02-19 | 2000-02-18 | Compuestos quimicos. |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP1150690A1 (es) |
JP (2) | JP2002537264A (es) |
CN (2) | CN1347323A (es) |
AU (2) | AU2834100A (es) |
BR (2) | BR0008297A (es) |
CA (2) | CA2362306A1 (es) |
CZ (2) | CZ20012965A3 (es) |
HU (2) | HUP0105280A2 (es) |
IL (2) | IL144895A0 (es) |
MX (2) | MXPA01008346A (es) |
NO (1) | NO309305B1 (es) |
PL (2) | PL350520A1 (es) |
RU (2) | RU2001123035A (es) |
SK (2) | SK11602001A3 (es) |
WO (2) | WO2000048609A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4182218B2 (ja) * | 2001-05-30 | 2008-11-19 | 学校法人東京理科大学 | アポトーシスを誘導する新規なグルコース誘導体、その製造方法及び医薬としてのその用途 |
DE10261807A1 (de) * | 2002-12-19 | 2004-07-01 | Turicum Drug Development Ag | Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel |
WO2007012650A1 (en) * | 2005-07-26 | 2007-02-01 | Nycomed Gmbh | Isotopically substituted proton pump inhibitors |
CN101268050B (zh) * | 2005-07-26 | 2012-11-28 | 奈科明有限责任公司 | 同位素取代的泮托拉唑 |
CA2624179A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
CN101157711B (zh) * | 2007-09-28 | 2010-12-08 | 西安交通大学 | 一种具有抗肿瘤活性的化合物及其用途 |
AU2009251848A1 (en) * | 2008-04-03 | 2009-12-03 | Cognate 3, Llc | Compositions and methods for immunotherapy |
CN101735284B (zh) * | 2008-11-24 | 2012-05-23 | 上海医药工业研究院 | 一种4,6-o-苄叉-d-吡喃葡萄糖的制备方法 |
EP3666271A1 (en) | 2013-12-03 | 2020-06-17 | Intra-Cellular Therapies, Inc. | Miscrospheres comprising a plga matrix for medical use |
HUE065482T2 (hu) * | 2014-04-04 | 2024-05-28 | Intra Cellular Therapies Inc | Deuterált heterociklus-fúzionált gamma-karbolinok mint 5-HT2A receptorok antagonistái |
JP6898072B2 (ja) * | 2015-08-27 | 2021-07-07 | 秀行 佐谷 | 14−3−3タンパク質活性調節剤 |
PT3407889T (pt) | 2016-03-25 | 2021-07-14 | Intra Cellular Therapies Inc | Compostos orgânicos e a sua utilização no tratamento ou prevenção de distúrbios do sistema nervoso central |
EP3525763A4 (en) | 2016-10-12 | 2020-06-17 | Intra-Cellular Therapies, Inc. | AMORPHE FIXED DISPERSIONS |
KR20220066988A (ko) | 2017-03-24 | 2022-05-24 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 조성물 및 방법 |
AU2019328528A1 (en) | 2018-08-31 | 2021-03-18 | Intra-Cellular Therapies, Inc. | Novel methods |
BR112021003838A2 (pt) | 2018-08-31 | 2021-05-18 | Intra-Cellular Therapies, Inc. | métodos novos |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB811510A (en) * | 1954-12-20 | 1959-04-08 | Gyogyszeripari Ki | New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof |
JPS6112623A (ja) * | 1984-06-28 | 1986-01-21 | Kaken Pharmaceut Co Ltd | エンケフアリナ−ゼ阻害剤 |
JPS6256423A (ja) * | 1985-09-06 | 1987-03-12 | Kaken Pharmaceut Co Ltd | 悪液質治療改善剤 |
US4874780A (en) * | 1987-03-11 | 1989-10-17 | Norsk Hydro A.S. | Anticancer compounds |
JPH07145191A (ja) * | 1993-11-24 | 1995-06-06 | Japan Tobacco Inc | ガラクトシルホスフォネート誘導体 |
-
1999
- 1999-02-19 NO NO990814A patent/NO309305B1/no not_active IP Right Cessation
-
2000
- 2000-02-18 MX MXPA01008346A patent/MXPA01008346A/es not_active Application Discontinuation
- 2000-02-18 CZ CZ20012965A patent/CZ20012965A3/cs unknown
- 2000-02-18 PL PL00350520A patent/PL350520A1/xx not_active Application Discontinuation
- 2000-02-18 CN CN00806488A patent/CN1347323A/zh active Pending
- 2000-02-18 AU AU28341/00A patent/AU2834100A/en not_active Abandoned
- 2000-02-18 CA CA002362306A patent/CA2362306A1/en not_active Abandoned
- 2000-02-18 SK SK1160-2001A patent/SK11602001A3/sk unknown
- 2000-02-18 CN CN00806338A patent/CN1347322A/zh active Pending
- 2000-02-18 AU AU28342/00A patent/AU2834200A/en not_active Abandoned
- 2000-02-18 CA CA002363670A patent/CA2363670A1/en not_active Abandoned
- 2000-02-18 RU RU2001123035/14A patent/RU2001123035A/ru unknown
- 2000-02-18 WO PCT/NO2000/000059 patent/WO2000048609A1/en not_active Application Discontinuation
- 2000-02-18 EP EP00906782A patent/EP1150690A1/en not_active Withdrawn
- 2000-02-18 MX MXPA01008347A patent/MXPA01008347A/es not_active Application Discontinuation
- 2000-02-18 IL IL14489500A patent/IL144895A0/xx unknown
- 2000-02-18 HU HU0105280A patent/HUP0105280A2/hu unknown
- 2000-02-18 IL IL14489600A patent/IL144896A0/xx unknown
- 2000-02-18 JP JP2000599401A patent/JP2002537264A/ja active Pending
- 2000-02-18 EP EP00906781A patent/EP1150689A1/en not_active Withdrawn
- 2000-02-18 SK SK1161-2001A patent/SK11612001A3/sk unknown
- 2000-02-18 RU RU2001123124/15A patent/RU2001123124A/ru unknown
- 2000-02-18 PL PL00350519A patent/PL350519A1/xx not_active Application Discontinuation
- 2000-02-18 BR BR0008297-0A patent/BR0008297A/pt not_active Application Discontinuation
- 2000-02-18 JP JP2000599400A patent/JP2002537263A/ja active Pending
- 2000-02-18 HU HU0105281A patent/HUP0105281A2/hu unknown
- 2000-02-18 BR BR0008302-0A patent/BR0008302A/pt not_active Application Discontinuation
- 2000-02-18 CZ CZ20012966A patent/CZ20012966A3/cs unknown
- 2000-02-18 WO PCT/NO2000/000060 patent/WO2000048610A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA01008346A (es) | 2003-06-06 |
CA2362306A1 (en) | 2000-08-24 |
NO990814D0 (no) | 1999-02-19 |
RU2001123124A (ru) | 2004-02-20 |
EP1150689A1 (en) | 2001-11-07 |
AU2834200A (en) | 2000-09-04 |
SK11612001A3 (sk) | 2002-04-04 |
WO2000048609A1 (en) | 2000-08-24 |
CZ20012966A3 (cs) | 2002-03-13 |
HUP0105281A2 (hu) | 2002-05-29 |
IL144896A0 (en) | 2002-06-30 |
SK11602001A3 (sk) | 2002-02-05 |
AU2834100A (en) | 2000-09-04 |
NO309305B1 (no) | 2001-01-15 |
CZ20012965A3 (cs) | 2002-03-13 |
CN1347323A (zh) | 2002-05-01 |
WO2000048610A1 (en) | 2000-08-24 |
BR0008297A (pt) | 2002-05-28 |
CN1347322A (zh) | 2002-05-01 |
JP2002537263A (ja) | 2002-11-05 |
PL350519A1 (en) | 2002-12-16 |
IL144895A0 (en) | 2002-06-30 |
RU2001123035A (ru) | 2004-03-20 |
EP1150690A1 (en) | 2001-11-07 |
PL350520A1 (en) | 2002-12-16 |
BR0008302A (pt) | 2002-08-27 |
CA2363670A1 (en) | 2000-08-24 |
JP2002537264A (ja) | 2002-11-05 |
NO990814L (no) | 2000-08-21 |
HUP0105280A2 (hu) | 2002-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1068626A1 (en) | Chemical compounds | |
MXPA01008347A (es) | Compuestos quimicos. | |
GB9722520D0 (en) | Compounds | |
BG106340A (en) | Substituted oxoazaheterocyclyl compounds | |
JO2654B1 (en) | Multiple aryl caroxa amides are useful as lipid - lowering agents | |
AU3652102A (en) | Compounds and their uses | |
DE602004021472D1 (en) | Pyrimiidinverbindungen | |
PL356486A1 (en) | Catalysts for hydrosilylation reactions | |
MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
IL155875A0 (en) | Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor | |
TW200510407A (en) | Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors | |
IL149370A0 (en) | 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them | |
MY128924A (en) | Novel compounds | |
DE60112330D1 (en) | Pyrazolopyridinderivate | |
MXPA04000210A (es) | Conjugados quelantes mejorados. | |
PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
SE9901077D0 (sv) | Novel use | |
WO2003027061A3 (en) | Muscarinic agonists | |
SE9801494D0 (sv) | Novel use | |
UA74430C2 (uk) | Похідні фенілгетероциклічних етерів як інгібітори зворотного захоплення серотоніну | |
YU76500A (sh) | Hemijska sinzeza morfolinskih derivata | |
TR200200494T2 (tr) | Yağlı asit sintazı inhibitörleri. | |
DE60201074D1 (en) | Pyrazolopyridinderivate | |
DK1206452T3 (da) | Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser | |
SE9904128D0 (sv) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |